Ontrak Shares Double As Data Shows Reduction in Depression, Anxiety Symptoms For Its Program Members - Ontrak (NASDAQ:OTRK)

Ontrak Inc OTRK announced initial assessment results showing that after six months, 30% of assessed Ontrak Wholehealth+ members sustained a clinically significant reduction in anxiety symptoms, and 55% sustained a clinically significant reduction of depressive symptoms.
Ontrak Health is one of the only behavioral services companies to institute formal PHQ-9 (a measure of depression severity) and GAD-7 (a measure of anxiety severity) assessments to gain valuable insights into their members' mental health care progress and support them.
In June 2022, Ontrak Health implemented PHQ-9 and GAD-7 assessments as foundational measurements of its care coaching model and evidence-based Wholehealth+ program.
While primarily used by providers, Ontrak Health has incorporated them into its care coaching model to promote better monitoring, collaboration, and accountability with its providers and customers.
Thousands of assessments have been completed representing results for more than 1,000 unique program enrollees.
By tracking changes in assessment scores over time, healthcare professionals can gauge the effectiveness of treatment interventions, identify issues, and take early action to address them.
Trending on assessment scores can help patients see progress over time. It is beneficial for patients who may have a history of chronic symptoms or are experiencing new mental health concerns. The data can provide a source of information in optimizing treatment.
Price Action: OTRK shares are up 111.3% at $1.2150 on the last check Wednesday.

Market News and Data brought to you by Benzinga APIs